ClinicalTrials.Veeva

Menu

HLA Sensitization in Severely Burned Patients

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Unknown

Conditions

Severely Burned Patients

Study type

Observational

Funder types

Other

Identifiers

NCT02537821
PKSF-01-2014

Details and patient eligibility

About

Primary goal of this study is the analysis of HLA (Human leucocyte antigen) formation in severly burned patients. Potential HLA triggers in the treatment of severely burned patients are blood products, assist devices or temporary allogeneic skin. Besides that, inflammatory markers, such as WBC (white blood cell count), CRP (C-reactive protein), PCT (Procalcitonin) and two novel biomarkers (PSP (pancreatic stone protein), ST2) are to be investigated in severely burned patients.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • severely burned patients in need for hospitalization

Exclusion criteria

  • hematologic diseases
  • Cancer

Trial contacts and locations

1

Loading...

Central trial contact

Jan Plock, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems